Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Rubin Lab
Explore this Website
Home
News
About Us
Research
Lab Team
Publications
Resources
Toggle Resources menu options
FISH
Profiler
Tracking Samples
Weill Cornell Medicine
Care
Discover
Teach
Home
News
About Us
Research
Lab Team
Publications
Resources
Home
Publications
Publications
Found 16 results
Author
Title
Type
Year
Filters:
Author
is
Hofer, Matthias D
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
T
Perner S
,
Demichelis F
,
Beroukhim R
,
Schmidt FH
,
Mosquera J-M
,
Setlur S
,
Tchinda J
,
Tomlins SA
,
Hofer MD
,
Pienta KG
et al.
. 2006.
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.
.
Cancer Res. 66(17):8337-41.
Perner S
,
Mosquera J-M
,
Demichelis F
,
Hofer MD
,
Paris PL
,
Simko J
,
Collins C
,
Bismar TA
,
Chinnaiyan AM
,
De Marzo AM
et al.
. 2007.
TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion.
.
Am J Surg Pathol. 31(6):882-8.
R
Hofer MD
,
Kuefer R
,
Varambally S
,
Li H
,
Ma J
,
Shapiro GI
,
Gschwend JE
,
Hautmann RE
,
Sanda MG
,
Giehl K
et al.
. 2004.
The role of metastasis-associated protein 1 in prostate cancer progression.
.
Cancer Res. 64(3):825-9.
Q
Rubin MA
,
Zerkowski MP
,
Camp RL
,
Kuefer R
,
Hofer MD
,
Chinnaiyan AM
,
Rimm DL
. 2004.
Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements.
.
Am J Pathol. 164(3):831-40.
P
Perner S
,
Hofer MD
,
Kim R
,
Shah RB
,
Li H
,
Möller P
,
Hautmann RE
,
Gschwend JE
,
Kuefer R
,
Rubin MA
. 2007.
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression.
.
Hum Pathol. 38(5):696-701.
Hofer MD
,
Kuefer R
,
Huang W
,
Li H
,
Bismar TA
,
Perner S
,
Hautmann RE
,
Sanda MG
,
Gschwend JE
,
Rubin MA
. 2006.
Prognostic factors in lymph node-positive prostate cancer.
.
Urology. 67(5):1016-21.
O
Rubin MA
,
Varambally S
,
Beroukhim R
,
Tomlins SA
,
Rhodes DR
,
Paris PL
,
Hofer MD
,
Storz-Schweizer M
,
Kuefer R
,
Fletcher JA
et al.
. 2004.
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer.
.
Cancer Res. 64(11):3814-22.
J
Santagata S
,
Demichelis F
,
Riva A
,
Varambally S
,
Hofer MD
,
Kutok JL
,
Kim R
,
Tang J
,
Montie JE
,
Chinnaiyan AM
et al.
. 2004.
JAGGED1 expression is associated with prostate cancer metastasis and recurrence.
.
Cancer Res. 64(19):6854-7.
I
Setlur SR
,
Royce TE
,
Sboner A
,
Mosquera J-M
,
Demichelis F
,
Hofer MD
,
Mertz KD
,
Gerstein M
,
Rubin MA
. 2007.
Integrative microarray analysis of pathways dysregulated in metastatic prostate cancer.
.
Cancer Res. 67(21):10296-303.
Hofer MD
,
Browne TJ
,
He L
,
Skotheim RI
,
Lothe RA
,
Rubin MA
. 2005.
Identification of two molecular groups of seminomas by using expression and tissue microarrays.
.
Clin Cancer Res. 11(16):5722-9.
G
Hofer MD
,
Kuefer R
,
Maier C
,
Herkommer K
,
Perner S
,
Demichelis F
,
Paiss T
,
Vogel W
,
Rubin MA
,
Hoegel J
. 2009.
Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.
.
Cancer Res. 69(2):640-6.
E
Hofer MD
,
Fecko A
,
Shen R
,
Setlur SR
,
Pienta KG
,
Tomlins SA
,
Chinnaiyan AM
,
Rubin MA
. 2004.
Expression of the platelet-derived growth factor receptor in prostate cancer and treatment implications with tyrosine kinase inhibitors.
.
Neoplasia. 6(5):503-12.
Perner S
,
Svensson MA
,
Hossain RR
,
Day JR
,
Groskopf J
,
Slaughter RC
,
Jarleborn AR
,
Hofer MD
,
Kuefer R
,
Demichelis F
et al.
. 2010.
ERG rearrangement metastasis patterns in locally advanced prostate cancer.
.
Urology. 75(4):762-7.
D
Demichelis F
,
Setlur SR
,
Beroukhim R
,
Perner S
,
Korbel JO
,
Lafargue CJ
,
Pflueger D
,
Pina C
,
Hofer MD
,
Sboner A
et al.
. 2009.
Distinct genomic aberrations associated with ERG rearranged prostate cancer.
.
Genes Chromosomes Cancer. 48(4):366-80.
Bismar TA
,
Demichelis F
,
Riva A
,
Kim R
,
Varambally S
,
He L
,
Kutok J
,
Aster JC
,
Tang J
,
Kuefer R
et al.
. 2006.
Defining aggressive prostate cancer using a 12-gene model.
.
Neoplasia. 8(1):59-68.
C
Mosquera J-M
,
Perner S
,
Genega EM
,
Sanda M
,
Hofer MD
,
Mertz KD
,
Paris PL
,
Simko J
,
Bismar TA
,
Ayala G
et al.
. 2008.
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.
.
Clin Cancer Res. 14(11):3380-5.